The Competition Commission of India (CCI) has approved the acquisition of 100% equity shares of Medlife International Private Limited (“Medlife”) by API Holdings Private Limited (“API Holdings”). It also approved the acquisition of up to 19.59% equity share capital of API Holdings by Medlife’s shareholders under Section 31(1) of the Competition Act, 2002.
API is a private company, incorporated in 2019. API directly or through its subsidiaries carries out various business activities including wholesale sale and distribution of drugs; transportation and delivery services primarily focused on pharmaceutical sector; owning technology and intellectual property for developing e- commerce platforms. Medlife is primarily a healthcare company engaged in the wholesale sale and distribution of drugs.
Important takeaways for all competitive exams:
In 2024, India lost several legendary figures who made remarkable contributions to art, literature, sports,…
Dr. Manmohan Singh, a brilliant economist and statesman, served as the 13th Prime Minister of…
India continues to establish itself as one of the leading global economies in 2024, with…
Indian public sector banks (PSBs) have reported strong profitability, with a 25% increase in net…
Nvidia has recently announced the launch of its Jetson Orin Nano Super Generative AI supercomputer,…
Osamu Suzuki, the long-serving chairman and CEO of Suzuki Motor Corporation, passed away at the…